Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, ...
Millions of people rely on statins, a medication used to lower cholesterol and reduce the risk of heart attack and stroke.
SurvivorNet on MSN
Taking Kisqali earlier helps prevent recurrence for patients with hormone receptor-positive breast cancer regardless of subtype
Adding targeted therapy Kisqali (ribociclib) to the standard treatment plan can significantly reduce the risk of cancer coming back for patients with hormone receptor-positive (HR+) breast cancer.
Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it, you might ...
Researchers used AI to analyze hundreds of thousands of Reddit posts about blockbuster weight-loss drugs like Ozempic and Mounjaro and found symptoms that may deserve closer attention. Credit: ...
In a sweeping analysis of more than 400,000 Reddit posts, researchers have revealed some little-known GLP-1 side effects. GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and ...
A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...
Kristie Reed, PharmD, oversees emergency, general medical, surgical, psychiatric care, and oncology medication as the pharmacy director of a community hospital. Dr. Reed specializes in IV medications.
Millions of people worldwide take antidepressants. While these drugs can be very effective in treating mental health conditions such as depression and anxiety, they can also cause a range of physical ...
There’s no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some unsightly downsides such as tooth decay, a droopy face or mouth, a saggy butt ...
The National Institute for Health and Care Excellence (NICE) has recommended ribociclib (Kisqali, Novartis) as an adjuvant treatment for early breast cancer in patients at high risk of recurrence. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results